| Financial Year |
December 31 2020 |
| Monetary Funds |
2,020,499,630.72 |
| Held-for-trading Financial Assets |
1,068,000,000.00 |
| Notes Receivable |
253,580,162.09 |
| Accounts Receivable |
2,371,968,301.04 |
| Advances to Suppliers |
8,099,279.39 |
| Other Receivables |
54,100,621.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,533,228.28 |
| Dividend Receivable |
-- |
| Inventories |
877,534,668.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
88,517,614.64 |
| Total Current Assets |
7,199,840,202.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,075,215,764.13 |
| Under-construction Projects |
814,751,634.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
244,550,174.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,668,211.52 |
| Deferred Income Tax Assets |
82,028,492.17 |
| Other Non-Current Assets |
665,453,354.51 |
| Sub-Total of Non-Current Assets |
4,905,667,631.84 |
| Total Assets |
12,105,507,834.35 |
| Short-Term Loans |
44,620,742.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
824,038,703.68 |
| Accounts Payable |
2,037,464,148.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
183,313,067.19 |
| Taxes Payable |
61,968,518.97 |
| Interest Payable |
2,582,813.33 |
| Dividend Payable |
-- |
| Other payables |
464,871,378.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
118,720.06 |
| Sub-Total of Current Liabilities |
3,619,432,838.86 |
| Long-term Loans |
9,775,586.35 |
| Bonds Payable |
1,471,987,223.73 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
86,510,350.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,729,246,898.57 |
| Total Liabilities |
5,348,679,737.43 |
| Paid-In Capital(Or Share Stock) |
853,483,694.00 |
| Capital Surplus |
1,928,492,225.57 |
| Surplus Reserve |
225,871,141.86 |
| LESS:Treasury Stock |
216,336,998.52 |
| Undistributed Profits |
3,447,586,131.99 |
| Minority Stockholder's Interest |
207,410,780.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,549,417,316.32 |
| Owner's Equity（Stockholder's Equity） |
6,756,828,096.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,105,507,834.35 |
